Acne vulgaris is a type of disorder that is characterized with the occurrence of seborrhea (scaly red skin), papules, pimples, comedones and nodules on the skin. Acne vulgaris primarily affects back, face and chest. Acne majorly affects teenagers however, its occurrence in adult population is also prominent. Onset of the disorder usually occurs at puberty due to increased secretion of sebum triggered by the action of high androgen levels. Also, during pregnancy, androgen level in the body increases hence increases the risk of acne vulgaris. It has been proven that acne vulgaris can be transmitted to next hereditary level, hence is also considered as hereditary disorder.
Request to View Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33911
Acne vulgaris is caused by Propionibacterium acnes and Staphylococcus aureus bacteria. Propionibacterium acnes is considered to be the most widely present acne-causing bacterium. Acne vulgaris on the body can be detected by their physical presence and morphology. However, depending upon the severity of the disorder, various diagnostic tests are performed for confirmation of the disorder that include Leeds acne grading technique, Pillsbury scale and Cook's acne grading scale. Therapy for treating the disorder depends upon the type of acne, their distribution on the body and severity.
Various medications are advised by physicians to treat acne vulgaris including benzoyl peroxide, salicylic acid, hormones (norgestimate, desogestrel and drospirenone), antibiotics, topical retinoids, oral retinoids, and combined therapy. Combined therapy refers to the application of multiple medications together such as combination of antibiotic + benzoyl peroxide and topical retinoid + benzoyl peroxide. Also, physical therapies are performed on patients suffering from acne vulgaris, including lesion removal and phototherapy.
Request Toc: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=33911
The market for acne vulgaris is expected to grow at a significant CAGR during the forecast period owing to increasing number of people suffering from the disorder. It is estimated that in the individuals aged 12 to 24 years, prevalence rate of the disorder is around 85%. In addition, change in dietary pattern will also stimulate the growth of the market. Major players operating in the market include Actavis Mid Atlantic LLC, Novan, Inc., Stiefel Laboratories, Inc., Dr. Reddy's Laboratories Limited and Johnson & Johnson.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request to Discount of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=33911
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453